Literature DB >> 18181150

The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34(cdc2) cyclin-dependent kinase.

Michael K Jones1, Oscar R Padilla, Nicole A Webb, Manith Norng.   

Abstract

The anti-apoptosis protein, survivin, promotes cell survival and mitosis. Recent studies have demonstrated that survivin is expressed in normal gastric mucosa. Using an in vitro model, we examined whether survivin plays a role in the cytoprotection produced in gastric mucosa by mild irritant ethanol (ETOH) against subsequent exposure to concentrated ETOH. Pre-treatment of rat gastric epithelial cells with 1% ETOH reduced cell death, in response to subsequent incubation with 5% ETOH, by 94% (P < 0.005). This pre-treatment also resulted in increased total and phosphorylated survivin protein levels by 180% (P < 0.0001) and 540% (P < 0.0002), respectively, which required the p34(cdc2) cell cycle-dependent kinase. The cytoprotective effect was abrogated upon siRNA knockdown of survivin protein levels. Further, overexpression of exogenous survivin resulted in significant cytoprotection by 62% (P < 0.02) in the absence of any pre-treatment. We further examined the in vivo relevance of these findings. In fasted rats, administration of 20% ETOH, which we found to be 93% (P < 0.0001) cytoprotective against 50% ETOH challenge, resulted in increased total and phosphorylated survivin protein levels by 234% (P < 0.001) and 214% (P < 0.02), respectively. Administration of 20% ETOH resulted in increased gastric p34(cdc2) activity by 146% (P < 0.01). Inhibition of p34(cdc2) by the potent inhibitor, roscovitine, abolished the increased survivin levels in response to pre-administration of 20% ETOH and reduced the cytoprotection against 50% ETOH challenge by 59% (P < 0.01). These results indicate that survivin is a key mediator of cytoprotection against ETOH-induced gastric injury, acting at the epithelial cell level, by a mechanism that is dependent, in part, on p34(cdc2). (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181150      PMCID: PMC2288653          DOI: 10.1002/jcp.21358

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  52 in total

1.  Control of apoptosis during angiogenesis by survivin expression in endothelial cells.

Authors:  D S O'Connor; J S Schechner; C Adida; M Mesri; A L Rothermel; F Li; A K Nath; J S Pober; D C Altieri
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Developmentally regulated expression of survivin in the human thymus.

Authors:  Yoshihiro Kobayashi; Haruhiro Yukiue; Hidefumi Sasaki; Ichiro Fukai; Tomoki Yokoyama; Masanobu Kiriyama; Yosuke Yamakawa; Masanobu Maeda; Yoshitaka Fujii
Journal:  Hum Immunol       Date:  2002-02       Impact factor: 2.850

3.  Adaptive gastric mucosal cytoprotection in rats: different modes of action by three mild irritants.

Authors:  J K Ko; C H Cho
Journal:  Digestion       Date:  1996       Impact factor: 3.216

Review 4.  Role of cyclooxygenase isoforms in gastric mucosal defence.

Authors:  B M Peskar
Journal:  J Physiol Paris       Date:  2001 Jan-Dec

5.  Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.

Authors:  S Fukuda; L M Pelus
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

6.  Activation of protein kinase C alters p34(cdc2) phosphorylation state and kinase activity in early sea urchin embryos by abolishing intracellular Ca2+ transients.

Authors:  F A Suprynowicz; L Groigno; M Whitaker; F J Miller; G Sluder; J Sturrock; T Whalley
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

7.  Gastric ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors.

Authors:  K Takeuchi; Y Ogawa; S Kagawa; H Ukawa
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

8.  Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa.

Authors:  R Gianani; E Jarboe; D Orlicky; M Frost; J Bobak; R Lehner; K R Shroyer
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

9.  Expression of survivin during liver regeneration.

Authors:  Masatoshi Deguchi; Katsuya Shiraki; Hidekazu Inoue; Hiroshi Okano; Takeshi Ito; Takenari Yamanaka; Kazushi Sugimoto; Takahisa Sakai; Shigeru Ohmori; Kazumoto Murata; Akihiro Furusaka; Hisashi Hisatomi; Takeshi Nakano
Journal:  Biochem Biophys Res Commun       Date:  2002-09-13       Impact factor: 3.575

10.  A p34(cdc2) survival checkpoint in cancer.

Authors:  Daniel S O'Connor; Nathan R Wall; Andrew C G Porter; Dario C Altieri
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

View more
  12 in total

Review 1.  Gastroduodenal mucosal defense.

Authors:  Amy Zhu; Jonathan Kaunitz
Journal:  Curr Gastroenterol Rep       Date:  2008-12

2.  A survivin-associated adaptive response in radiation therapy.

Authors:  David J Grdina; Jeffrey S Murley; Richard C Miller; Helena J Mauceri; Harold G Sutton; Jian Jian Li; Gayle E Woloschak; Ralph R Weichselbaum
Journal:  Cancer Res       Date:  2013-05-07       Impact factor: 12.701

3.  Inhibition of caspase-3 by Survivin prevents Wee1 Kinase degradation and promotes cell survival by maintaining phosphorylation of p34Cdc2.

Authors:  Javier Rivera Guzman; Seiji Fukuda; Louis M Pelus
Journal:  Gene Ther Mol Biol       Date:  2009

4.  Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury.

Authors:  M K Jones; O R Padilla; E Zhu
Journal:  J Physiol Pharmacol       Date:  2010-06       Impact factor: 3.011

5.  Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells.

Authors:  B Voellger; N Waldt; Rosita Rupa; E Kirches; O Melhem; H-J Ochel; C Mawrin; R Firsching
Journal:  J Neurooncol       Date:  2018-06-05       Impact factor: 4.130

Review 6.  Alcohol exposure and mechanisms of tissue injury and repair.

Authors:  M Katherine Jung; John J Callaci; Kristen L Lauing; Jeffrey S Otis; Katherine A Radek; Michael K Jones; Elizabeth J Kovacs
Journal:  Alcohol Clin Exp Res       Date:  2010-11-30       Impact factor: 3.455

7.  Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro.

Authors:  Rachel M A Barrett; Rita Colnaghi; Sally P Wheatley
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

8.  Ghrelin inhibition of ethanol-induced gastric epithelial cell apoptosis is mediated by miR-21.

Authors:  Miao Jiang; Peng-Fei Gao; Huan-Qing Li; Pei-Ying Tian; Xiao-Ming Fan
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

9.  Liaisons between survivin and Plk1 during cell division and cell death.

Authors:  Rita Colnaghi; Sally P Wheatley
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

10.  Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat.

Authors:  Benjamin Voellger; Elmar Kirches; Annette Wilisch-Neumann; Andreas Weise; Jorge Humberto Tapia-Perez; Rosita Rupa; Christian Mawrin; Raimund Firsching
Journal:  Onco Targets Ther       Date:  2013-09-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.